Hospital
ST. John's Episcopal Hospital
ST. John's Episcopal Hospital was paid $10.22M by Medicaid between Jan 2019 and Nov 2024, across 142 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 20% of everything it billed.
33Billing provider infoST. JOHN'S EPISCOPAL HOSPITAL
FAR ROCKAWAY, NY 11691
FAR ROCKAWAY, NY 11691
33aNPI1245475144assigned 12/05/2008
33bProvider typeGeneral Acute Care Hospital
28Total paid$10.22M
24GClaims143,683
24DCodes billed142
24AFirst – last monthJan 2019 – Nov 2024
Compared with peers
Next to other General Acute Care Hospital providers in New York
Rank by total paid#82 of 231
Median peer was paid$561K
This provider vs. median18×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 6,881 | $359K | |
| 2020 | 20,901 | $1.03M | |
| 2021 | 29,329 | $1.63M | |
| 2022 | 29,832 | $3.56M | |
| 2023 | 34,640 | $2.44M | |
| 2024incomplete | 22,100 | $1.20M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 20% | 10,860 | 9,433 | $2.00M |
| 90832 | Psychotherapy session, about 30 minutesPsychotherapy, 30 minutes with patient | 15% | 7,631 | 4,392 | $1.53M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 14% | 7,203 | 6,706 | $1.44M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 6.9% | 4,373 | 4,060 | $709K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 6.3% | 2,816 | 2,726 | $640K |
| 36415 | Collection of venous blood by venipuncture | 5.5% | 7,111 | 6,604 | $559K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 4.7% | 2,743 | 2,495 | $482K |
| 96361 | Intravenous infusion, hydration; each additional hour | 4.0% | 1,478 | 1,351 | $409K |
| 70450 | Computed tomography, head or brain; without contrast material | 3.5% | 1,157 | 1,121 | $357K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 2.6% | 1,745 | 1,670 | $266K |
| 80053 | Comprehensive metabolic panel | 2.1% | 7,470 | 6,577 | $213K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 2.1% | 1,198 | 1,126 | $211K |
130 more codes
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 1.5% | 602 | $151K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1.1% | 2,791 | $116K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 1.1% | 696 | $109K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 375 | $90K |
| 86850 | <1% | 991 | $89K | |
| 81025 | <1% | 2,542 | $81K | |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 363 | $61K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 447 | $60K |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 264 | $52K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 257 | $49K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 1,355 | $48K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 164 | $42K |
| 99443 | <1% | 430 | $41K | |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 240 | $36K |
| 80061 | Lipid panel | <1% | 1,794 | $30K |
| 86703 | <1% | 1,005 | $28K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 938 | $28K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 595 | $25K |
| 90686 | <1% | 1,032 | $22K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 477 | $20K |
| 98968 | <1% | 193 | $18K | |
| 92551 | <1% | 198 | $17K | |
| 99442 | <1% | 143 | $15K | |
| 99188 | <1% | 268 | $15K | |
| 90791 | Psychiatric diagnostic evaluation | <1% | 60 | $13K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 80 | $12K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 39 | $11K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 59 | $9K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 1,735 | $8K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 145 | $8K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 46 | $7K |
| 99441 | <1% | 52 | $6K | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 97 | $6K |
| 99173 | <1% | 145 | $6K | |
| 86480 | <1% | 78 | $5K | |
| G0378 | Hospital observation service, per hour | <1% | 220 | $5K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 212 | $5K |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | <1% | 154 | $5K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 237 | $5K |
| 36416 | <1% | 68 | $4K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 24 | $4K |
| 83655 | <1% | 205 | $3K | |
| 90715 | <1% | 135 | $3K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,286 | $3K |
| 76641 | <1% | 120 | $3K | |
| 83880 | <1% | 105 | $3K | |
| 90671 | <1% | 108 | $2K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 9,183 | $2K |
| 0002A | <1% | 79 | $2K | |
| 90853 | Group psychotherapy (other than of a multiple-family group) | <1% | 23 | $2K |
| 99401 | <1% | 15 | $2K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 2,816 | $2K |
| 0001A | <1% | 100 | $2K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 1,947 | $2K |
| 90688 | <1% | 89 | $1K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 1,826 | $1K |
| 84439 | <1% | 1,746 | $1K | |
| 90672 | <1% | 63 | $1K | |
| 85610 | <1% | 1,930 | $955.63 | |
| 90670 | <1% | 51 | $856.80 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,647 | $620.07 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 576 | $572.40 |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 962 | $488.38 |
| 85730 | <1% | 1,802 | $466.63 | |
| 81003 | <1% | 5,006 | $400.29 | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 64 | $355.54 |
| 90734 | <1% | 14 | $351.40 | |
| 90697 | <1% | 13 | $326.30 | |
| 90651 | <1% | 13 | $301.21 | |
| 82962 | <1% | 3,148 | $277.82 | |
| 71045 | Radiologic examination, chest; single view | <1% | 2,139 | $267.99 |
| 86592 | <1% | 1,019 | $266.46 | |
| 90685 | <1% | 13 | $232.05 | |
| 90662 | <1% | 12 | $229.50 | |
| 87340 | <1% | 461 | $209.20 | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 43 | $205.24 |
| 73562 | <1% | 91 | $199.17 | |
| 86803 | <1% | 310 | $191.62 | |
| 82607 | <1% | 183 | $176.09 | |
| 73630 | <1% | 98 | $173.94 | |
| 87210 | <1% | 2,391 | $149.06 | |
| 84484 | <1% | 2,716 | $130.09 | |
| 84702 | <1% | 735 | $86.71 | |
| 84703 | <1% | 1,015 | $80.32 | |
| 96127 | <1% | 900 | $72.21 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 861 | $50.00 |
| 82746 | <1% | 15 | $37.50 | |
| 73130 | <1% | 53 | $30.16 | |
| 83690 | <1% | 1,522 | $23.06 | |
| 85027 | <1% | 394 | $20.77 | |
| 82550 | <1% | 2,021 | $16.80 | |
| 73610 | <1% | 34 | $15.16 | |
| 86710 | <1% | 303 | $14.99 | |
| 85007 | <1% | 461 | $14.86 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 608 | $11.07 |
| 83735 | <1% | 448 | $10.06 | |
| 83605 | <1% | 687 | $9.39 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 311 | $8.74 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,412 | $3.94 |
| 85048 | <1% | 38 | $3.13 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 174 | $3.06 |
| 85651 | <1% | 12 | $2.00 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 365 | $1.25 |
| 94760 | <1% | 791 | $0.78 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 1,077 | $0.44 |
| J7030 | Infusion, normal saline solution , 1000 cc | 0% | 1,879 | $0.00 |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 0% | 2,250 | $0.00 |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 0% | 327 | $0.00 |
| 90461 | 0% | 365 | $0.00 | |
| 87420 | 0% | 131 | $0.00 | |
| 91300 | 0% | 50 | $0.00 | |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 0% | 93 | $0.00 |
| J1650 | Injection, enoxaparin sodium, 10 mg | 0% | 53 | $0.00 |
| 86787 | 0% | 12 | $0.00 | |
| 85378 | 0% | 41 | $0.00 | |
| 84100 | 0% | 17 | $0.00 | |
| 82553 | 0% | 543 | $0.00 | |
| 96375 | Therapeutic injection; each additional sequential IV push | 0% | 1,186 | $0.00 |
| J2060 | Injection, lorazepam, 2 mg | 0% | 16 | $0.00 |
| 84132 | 0% | 160 | $0.00 | |
| 80320 | 0% | 226 | $0.00 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 0% | 14 | $0.00 |
| J7060 | 5% dextrose/water (500 ml = 1 unit) | 0% | 42 | $0.00 |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 0% | 13 | $0.00 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 0% | 18 | $0.00 |
| 86706 | 0% | 13 | $0.00 | |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | 0% | 13 | $0.00 |
| J1630 | Injection, haloperidol, up to 5 mg | 0% | 14 | $0.00 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 0% | 12 | $0.00 |
| 86762 | 0% | 14 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialCALDERONE, DIANE (SOCIAL WORKER)